Physostigmine Restores Impaired Autophagy in the Rat Hippocampus after Surgery Stress and LPS Treatment

Tissue damage and pathogen invasion during surgical trauma have been identified as contributing factors leading to neuroinflammation in the hippocampus, which can be protected by stimulation of the cholinergic anti-inflammatory pathway using the acetylcholinesterase inhibitor physostigmine. macroautophagy, an intracellular degradation pathway used to recycle and eliminate damaged proteins and organelles by lysosomal digestion, seems to be important for cell survival under stress conditions. this study aimed to examine the role of autophagy in physostigmine-mediated hippocampal cell protection in a rat model of surgery stress. in the presence or absence of physostigmine, adult wistar rats underwent surgery in combination with lipopolysaccharide (lps). activated microglia, apoptosis-, autophagy-, and anti-inflammatory-related genes and -proteins in the hippocampus were determined by real-time pcr, western blot and fluorescence microscopy after 1 h, 24 h and 3 d. surgery combined with lps-treatment led to microglia activation after 1 h and 24 h which was accompanied by apoptotic cell death after 24 h in the hippocampus. furthermore, it led to a decreased expression of atg-3 after 24 h and an increased expression of p62/ sqstm1 after 1 h and 24 h. administration of physostigmine significantly increased autophagy related markers and restored the autophagic flux after surgery stress, detected by increased degradation of p62/ sqstm1 in the hippocampus after 1 h and 24 h. furthermore, physostigmine reduced activated microglia and apoptosis relevant proteins and elevated the increased expression of tgf-beta1 and mfg-e8 after surgery stress. in conclusion, activation of autophagy be essential in physostigmine-induced neuroprotection against surgery stress.